Bio-Rad Laboratories (NYSE:BIO.B) Releases Earnings Results

Bio-Rad Laboratories (NYSE:BIO.B) issued its earnings results on Thursday. The company reported $2.90 EPS for the quarter, Zacks reports. Bio-Rad Laboratories had a negative net margin of 30.18% and a positive return on equity of 3.74%.

Bio-Rad Laboratories Price Performance

Bio-Rad Laboratories stock opened at $312.05 on Friday. Bio-Rad Laboratories has a 12-month low of $279.91 and a 12-month high of $359.22. The stock has a market cap of $8.74 billion, a P/E ratio of -11.42 and a beta of 0.73. The company has a 50-day moving average price of $337.86 and a 200 day moving average price of $332.76. The company has a current ratio of 6.14, a quick ratio of 4.52 and a debt-to-equity ratio of 0.16.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.